| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/03/2002 | EP1218406A1 Nucleic acids and secreted polypeptides encoded thereby |
| 07/03/2002 | EP1218400A1 Compositions and methods for the diagnosis and treatment of immune disorders |
| 07/03/2002 | EP1218397A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 07/03/2002 | EP1218396A1 Antibodies specific for fullerenes |
| 07/03/2002 | EP1218036A1 Cell based assay |
| 07/03/2002 | EP1218032A1 Treatment of refractory human tumors with epidermal growth factor receptor antagonists |
| 07/03/2002 | EP1217891A1 Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family |
| 07/03/2002 | EP1034292B1 Cell-specific retroviral vectors with antibody domains and method for the production thereof for selective gene transfer |
| 07/03/2002 | EP0892854B1 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 07/03/2002 | EP0813423B1 Composition to inhibit osteolysis and metastasis |
| 07/03/2002 | EP0672062B1 A petroleum immunoassay method and its components |
| 07/03/2002 | EP0619324B1 HUMAN TYPE ANTIBODY REACTIVE WITH GPIIb/IIIa |
| 07/03/2002 | CN1357109A Removal of prions from blood, plasma and other liquids |
| 07/03/2002 | CN1357047A Recombinant fusion protein (vaccine) compsn. contg. same and method for prodn. thereof |
| 07/03/2002 | CN1357046A Chitinase chitin-binding fragments |
| 07/03/2002 | CN1357045A Outer surface proteins, their genes, and their use |
| 07/03/2002 | CN1357042A Interleukin-17 related mammalian cytokines, polynucleotides encoding them. uses |
| 07/03/2002 | CN1357041A Head trauma induced cytoplasmatic calcium binding protein |
| 07/03/2002 | CN1357009A Humanized antibody specific for human 4-1BB and pharmaceutical compsn comprising same |
| 07/03/2002 | CN1357006A Mage-A1 peptides presented by HLA class II molecules |
| 07/03/2002 | CN1356911A Method for treatment of fibrosis using antagonist of integrin alpha-4 subunit |
| 07/03/2002 | CN1356909A Treatment of hemoatological malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody |
| 07/03/2002 | CN1356550A Reagent kit for diagnosing white-spot baculovirus of prawn and its test method |
| 07/03/2002 | CN1356341A Anti-idiotype microantibody and its preparing process and application |
| 07/03/2002 | CN1356340A Single-chain antibody A1 for recognizing white-spot baculovirus of prawn and its usage |
| 07/03/2002 | CN1356339A High-expression gene of liver cancer, protein coded by it and its application |
| 07/03/2002 | CN1356144A Process for generating antibody in bird by use of transfer code sequence |
| 07/02/2002 | US6414129 Cells containing expression vectors; diagnosis; immunomodulator detection; genetic engineering |
| 07/02/2002 | US6414128 Leptin ligand binding; medical diagnosis, therapy, agonists, and antagonists; genetic engineering |
| 07/02/2002 | US6414117 Compositions and methods for the treatment and diagnosis of immune disorders |
| 07/02/2002 | US6414116 Immunoreactive regions of glycoprotein GPII of varicella zoster virus |
| 07/02/2002 | US6414115 Parasitic nematode transglutaminase proteins and uses thereof |
| 07/02/2002 | US6413939 Inducible phosphofructokinase and the Warburg effect |
| 07/02/2002 | US6413932 Tek antagonists comprising soluble tek extracellular binding domain |
| 07/02/2002 | US6413777 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
| 07/02/2002 | US6413774 Producing recombinant nucleic acid using cycles of hybridization, chain extension, and denaturation; then transferring into cells for recombining |
| 07/02/2002 | US6413771 Respiratory syncytial virus (rsv) fusion protein; treating or preventing rsv infection, as well as for diagnosis of rsv in analytes |
| 07/02/2002 | US6413770 NL4 tie ligand homologue nucleic acid |
| 07/02/2002 | US6413764 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof |
| 07/02/2002 | US6413756 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/02/2002 | US6413755 Human checkpoint kinase, HCDS1, compositions and methods |
| 07/02/2002 | US6413746 Producing immunoglobulin by culturing animal hybridoma cells in presence of alkanoic acid or salt at concentration of 0.1 to 200 mm which enhances protein production but does not affect cell growth, accumulating, and recovering protein |
| 07/02/2002 | US6413740 Nucleic acid which codes for muscle specific kinase c-terminal fragment of human agrin; diagnosis and treatment of muscle disorders and neuromusclar disorders |
| 07/02/2002 | US6413735 Method of screening for a modulator of angiogenesis |
| 07/02/2002 | US6413731 Methods of screening for compounds which bind to a human SNORF36A receptor |
| 07/02/2002 | US6413727 Detecting somatic alteration of wild-type protein in tumor tissue by immunoblotting; prognosis of cancer |
| 07/02/2002 | US6413719 KCNQ2 and KCNQ3-potassium channel genes which are mutated in benign familial neonatal convulsions (BFNC) and other epilepsies |
| 07/02/2002 | US6413715 β(1-3)-glucan diagnostic assays |
| 07/02/2002 | US6413550 Proteinoid carriers and methods for preparation and use thereof |
| 07/02/2002 | US6413524 spsA polynucleotides and polypeptides |
| 07/02/2002 | US6413522 Papilloma viruses, products for the detection thereof as well as for treating diseases caused by them |
| 07/02/2002 | US6413516 Suppression lymphocytes |
| 07/02/2002 | US6413515 Vaccines |
| 07/02/2002 | US6413514 Methods of using antibodies against human CD40 |
| 07/02/2002 | CA2184908C Human osteoclast-derived cathepsin |
| 07/02/2002 | CA2123696C Antitumor vaccines |
| 07/02/2002 | CA2083172C Protein d - an igd-binding protein of haemophilus influenzae |
| 07/02/2002 | CA2073486C Composition for the prevention of lyme disease and use for |
| 07/02/2002 | CA2050749C Nucleotide sequence coding for an outer membrane protein from neisseria meningitidis and use of said protein in vaccine preparations |
| 07/02/2002 | CA2047792C Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines |
| 07/02/2002 | CA1341373C Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates |
| 06/27/2002 | WO2002050550A2 Oxidised low-density lipoproteins (ldl) fractions |
| 06/27/2002 | WO2002050545A2 Compositions and methods involving staphylococcus aureus protein staau-r9 |
| 06/27/2002 | WO2002050303A2 Protein-protein interactions |
| 06/27/2002 | WO2002050289A1 Methods for the production of multimeric proteins, and related compositions |
| 06/27/2002 | WO2002050286A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 06/27/2002 | WO2002050285A2 Histone deacetylase-related gene and protein |
| 06/27/2002 | WO2002050284A2 Oxidoreductases |
| 06/27/2002 | WO2002050283A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 06/27/2002 | WO2002050280A2 Equine ige allotype |
| 06/27/2002 | WO2002050279A2 Nucleic acid-associated proteins |
| 06/27/2002 | WO2002050266A1 Novel g protein-coupled receptor protein and dna thereof |
| 06/27/2002 | WO2002050257A2 Method for the production of polyfructans |
| 06/27/2002 | WO2002050255A2 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof |
| 06/27/2002 | WO2002050250A2 Signal-1/signal-2 bifunctional peptide inhibitors |
| 06/27/2002 | WO2002050123A2 Stabilization of antibodies or fragments thereof |
| 06/27/2002 | WO2002050122A2 Means for the diagnosis and therapy of ctcl |
| 06/27/2002 | WO2002050121A1 Novel antibody |
| 06/27/2002 | WO2002050120A2 High affinity antibodies |
| 06/27/2002 | WO2002050119A2 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 06/27/2002 | WO2002050118A2 Single-strand antibody with improved stability |
| 06/27/2002 | WO2002050113A2 Interleukin-1 related gene and protein |
| 06/27/2002 | WO2002050108A2 Immunogenic glycopeptides, screening, preparation and uses |
| 06/27/2002 | WO2002050106A2 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4 |
| 06/27/2002 | WO2002050096A1 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 06/27/2002 | WO2002020822A3 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 06/27/2002 | WO2002016548A3 Novel g protein-coupled receptor |
| 06/27/2002 | WO2002016433A3 Two receptors of meiosis activating sterols designated sam1a and sam1b |
| 06/27/2002 | WO2002016415A3 Identification of a cam-kinase ii inhibitor |
| 06/27/2002 | WO2002000882A3 Transport peptides dirived from erns protein, cytotoxic rnase of ribosome-inactivating protein or a rsv g-protein and analogues thereof |
| 06/27/2002 | WO2001098523A3 Detection method of genetic recombinant food and detection kit of that |
| 06/27/2002 | WO2001087938A3 Polynucleotide sequence encoding a putative cell adhesion molecule |
| 06/27/2002 | WO2001073025A3 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
| 06/27/2002 | WO2001070978A3 Polypeptides and nucleic acids encoding same |
| 06/27/2002 | WO2001040277A3 Carbohydrate-aminated glycoproteins |
| 06/27/2002 | WO2001030393A8 Methods for reducing the effects of cancers that express a33 antigen using a33 antigen specific immunoglobulin products |
| 06/27/2002 | WO2001014536A3 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 06/27/2002 | WO2001012217A9 Therapeutic antibody against muc-1 antigen and methods for their use |
| 06/27/2002 | WO2000069879A9 Ca7 cg04 gene |
| 06/27/2002 | US20020082412 Methods |